ZA875378B - Purified fetal thymidine kinase - Google Patents

Purified fetal thymidine kinase

Info

Publication number
ZA875378B
ZA875378B ZA875378A ZA875378A ZA875378B ZA 875378 B ZA875378 B ZA 875378B ZA 875378 A ZA875378 A ZA 875378A ZA 875378 A ZA875378 A ZA 875378A ZA 875378 B ZA875378 B ZA 875378B
Authority
ZA
South Africa
Prior art keywords
purified
thymidine kinase
thymidine
purified fetal
relates
Prior art date
Application number
ZA875378A
Other languages
English (en)
Inventor
Nicolas Jouan Pierre
Original Assignee
Laboratoires Debat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Debat filed Critical Laboratoires Debat
Publication of ZA875378B publication Critical patent/ZA875378B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211Thymidine kinase (2.7.1.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA875378A 1986-07-31 1987-07-22 Purified fetal thymidine kinase ZA875378B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611101A FR2602242B1 (fr) 1986-07-31 1986-07-31 Thymidine kinase de type foetal purifiee

Publications (1)

Publication Number Publication Date
ZA875378B true ZA875378B (en) 1988-01-29

Family

ID=9337917

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875378A ZA875378B (en) 1986-07-31 1987-07-22 Purified fetal thymidine kinase

Country Status (14)

Country Link
EP (1) EP0255431B1 (de)
JP (1) JPS6359886A (de)
CN (1) CN87105215A (de)
AT (1) ATE68821T1 (de)
AU (1) AU594486B2 (de)
DE (1) DE3774025D1 (de)
DK (1) DK387387A (de)
ES (1) ES2038681T3 (de)
FR (1) FR2602242B1 (de)
GR (1) GR3003416T3 (de)
IE (1) IE61237B1 (de)
NZ (1) NZ221246A (de)
PT (1) PT85406B (de)
ZA (1) ZA875378B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004758A1 (en) * 1993-08-06 1995-02-16 Brigham Young University Technology Transfer Office Monoclonal antibodies to thymidine kinase isozymes
SE9401380D0 (sv) * 1994-04-22 1994-04-22 Sven Skog Ny celltillväxt-relaterad peptid och användning därav
CN1301821A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——胸腺嘧啶核苷酸激酶11和编码这种多肽的多核苷酸
US7311906B2 (en) 2004-04-30 2007-12-25 Brigham Young University Anti-viral activity of an anti-thymidine kinase monoclonal antibody
US7837998B2 (en) 2004-05-21 2010-11-23 Nathaniel Lallatin Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
US8551486B2 (en) 2004-05-21 2013-10-08 Savoy Pharmaceuticals, Inc. Monoclonal antibodies to human thymidine kinase to treat cancer
US9267948B2 (en) 2009-12-30 2016-02-23 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2028588A1 (de) * 1970-06-10 1971-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur Gewinnung von Thymidin-Kinase

Also Published As

Publication number Publication date
ES2038681T3 (es) 1993-08-01
IE872064L (en) 1988-01-31
AU594486B2 (en) 1990-03-08
CN87105215A (zh) 1988-02-24
FR2602242A1 (fr) 1988-02-05
FR2602242B1 (fr) 1989-05-26
AU7607587A (en) 1988-02-04
DK387387A (da) 1988-02-01
NZ221246A (en) 1991-05-28
DK387387D0 (da) 1987-07-24
JPS6359886A (ja) 1988-03-15
PT85406B (pt) 1990-04-30
ATE68821T1 (de) 1991-11-15
DE3774025D1 (de) 1991-11-28
PT85406A (fr) 1987-08-01
IE61237B1 (en) 1994-10-19
EP0255431B1 (de) 1991-10-23
JPH0438392B2 (de) 1992-06-24
EP0255431A1 (de) 1988-02-03
GR3003416T3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
BR9106140A (pt) Mistura de reacao para oxidacao de olefina em produto de carbonila,processo de wacker para fabricacao de acetaldeido por oxidacao de etileno,processo para oxidacao de olefina em produto de carbonila e processo para oxidacao de vanadio (iv) em vanadio (v)
IL81669A0 (en) Aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles,their preparation and pharmaceutical compositions containing them
DE69014186D1 (de) Verfahren zur Herstellung von Detergenszubereitungen mit hoher Schüttdichte.
DE69031791T2 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
UA18261A (uk) Спосіб одержаhhя простих перфторполіефірів
EP0256228A3 (de) Verfahren zur Alkylierung von Cyclopentadien oder einem Derivat davon
IL60185A (en) 6 beta,7 beta;15,16-dimethylene-1,4-androstadien-3-ones,process for their production and pharmaceutical preparations containing them
AR242187A1 (es) Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
ZA875378B (en) Purified fetal thymidine kinase
FR2526419B1 (fr) Procede et composition catalytique pour produire un alkyleneglycol inferieur et procede pour preparer cette composition
EP0192988A3 (en) Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
ATE166045T1 (de) Verfahren zur herstellung von tertiärem butylamin
DE69010048D1 (de) Verfahren zur Herstellung massiger Vliesstoffe.
AU2765788A (en) Process for the catalytic hydration of olefins
PT87309A (pt) Process for the preparation of benzazepine by products
PT87503A (pt) Process for the preparation of new cathecolamine by products
IL88732A0 (en) Process for making alkyl arsine compounds
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
FR2704773B1 (fr) Procédé de préparation de catalyseurs utilisables en déshydrogénation.
NO882255L (no) Fremgangsmaate for fremstilling av olefin-maleinsyreanhydrid-kopolymer i form av partikler.
DE69319358T2 (de) Verfahren zur Herstellung von Alkylarsinverbindungen
EP0287007A3 (en) Process for cleaving aliphatic ether compounds
ATE40380T1 (de) Anthracykline verbindung, verfahren zu deren herstellung, deren pharmazeutische zusammensetzung und deren verwendung als arzneimittel.
PT84036A (en) Process for the preparation of benzothiazepin by products
IT210806Z2 (it) Dispositivo di movimentazione da impiegare in macchine per laproduzione di articoli di vetreria.